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ABSTRACT 
Objective: The aim of the present investigation was to design and evaluate fast dissolving tablet (FDT) for the oral delivery containing solid 
dispersion of meclizine (MCZ) hydrochloride, an antiemetic drug.  
Methods: The solubility of meclizine was increased by preparing solid dispersions using mannitol as a carrier by fusion method. The prepared solid 
dispersion, was subjected for in vitro drug release, percent practical yield, drug content, infrared spectroscopy (IR), differential scanning 
calorimetry (DSC), scanning electron microscopy (SEM). Optimized solid dispersion was incorporated to prepare fast dissolving tablets. 
Preformulation studies were carried out on tablet blends. The prepared solid dispersion, as well as pure drug fast dissolving tablets, was evaluated 
for drug content, weight variation, hardness, friability, in vitro drug release, wetting time, disintegration time, water absorption ratio, in vitro 
dispersion time. 
Results: Meclizine pure drug, solid dispersions formulations SD1, SD3 and SD5 showed 12.8, 31.68, 38.92 and 53.28% cumulative drug release in 
phosphate buffer pH 6.8 after 60 min, respectively. Thus faster dissolution rate was exhibited by the solid dispersion containing 1:5 (w/w) ratio of 
meclizine: mannitol. Percent cumulative drug release for control and solid dispersion tablets after 60 min in phosphate buffer pH 6.8 was 92.04 and 
98.2% respectively. The release of drug meclizine from best formulation SD5 FDT was found to be faster than pure drug FDT. 
Conclusion: Fast dissolving tablet of optimized solid dispersion showed better in vitro dissolution result then FDT of pure drug at the end of one 
hour.  
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Solubility is an important physicochemical factor affecting 
absorption of the drug and its therapeutic effectiveness. Formulation 
development scientists are focusing on the development of oral 
dosage forms of poor aqueous solubility drugs through various 
solubility enhancing approaches. Among these approaches, 
preparation of solid dispersion is one of the widely used approaches 
to enhance the solubility and dissolution rate of poorly water-
soluble drugs. Solid dispersions are defined as molecular 
dispersions of drugs in a polymer in solid form [1, 2]. 
Solid dispersions of fenofibrate were prepared using PEG 6000, 
poloxamer 407 and a mixture of polyethylene glycol 6000 (PEG 
6000) and poloxamer 407 [3]. The solid dispersion of terbinafine 
HCl was prepared with PEG 6000 and mannitol to increase water 
solubility [4]. Solid dispersions of carvedilol with polyvinyl 
pyrrolidone (PVP K30) were prepared to improve solubility [5]. 
The present study is aimed to formulate and develop meclizine 
hydrochloride (MCZ) fast dissolving tablets of using solid dispersion 
method to improve the solubility and dissolution rate. MCZ is a first-
generation antihistamine acting as H1 receptor antagonist and 
practically insoluble in water. MCZ is widely used in the treatment of 
motion sickness, but due to poor water solubility has delayed the 
onset of action [6]. To overcome this problem, this drug is selected 
for the present study and hence find advantageous to pediatric and 
geriatric patients who generally show the problem in swallowing.  
The solid dispersion of MCZ was prepared by the solvent evaporation 
method using polyethylene glycol 4000 and 6000 as a carrier [7]. MCZ 
orodispersible tablets were prepared by using direct compression 
method [8]. MCZ fast dissolving tablets using sublimation method 
were prepared to enhance the dissolution rate [9]. 
Fast dissolving tablet (FDT) is defined as “a solid dosage form 
containing a medicinal substance or active ingredient which 
disintegrates rapidly usually within a matter of seconds when placed 
upon the tongue. Hoon Jeong, et al. reviewed that the different 
material properties for making fast dissolving tablets by a 
compression Method. Fast dissolving tablets (FDTs) are prepared by 
several different methods including crystalline transition, phase 
transition, sublimation, spray drying, and direct compression [10]. 
The goal of the present investigation was to design and evaluate fast 
dissolving tablet for the oral delivery containing the solid dispersion 
of water-insoluble antiemetic drug-meclizine with an aim to 
increase its solubility and dissolution rate. This is an novel approach 
that uses a mannitol as a carrier to prepare sustained release solid 
dispersion in different ratio. 
MATERIALS AND METHODS 
Materials 
Meclizine Hydrochloride was obtained from Symed Labs Limited, 
Hyderabad, Telangana, India and mannitol from Amisha Chemicals, 
Ahmedabad, India as a gift sample. crospovidone and magnesium 
stearate were bought from Signet chemical Pvt. Ltd., Mumbai, India, 
spray dried lactose from Pfizer Ltd., Goa, India and purified talc from 
West coast laboratories, Mumbai, India. All reagents used were of 
analytical grade. 
Methodology 
Preparation of calibration curve of meclizine in water, 0.1N HCl, 
and phosphate buffer pH 6.8 
A standard stock solution containing 100 µg/ml was prepared in 
methanol. From the working standard solution concentration of 2-
20 µg/ml were prepared by dilution with water, 0.1N HCl and 
phosphate buffer pH 6.8. The calibration curve for MCZ was plotted 
on concentration v/s absorbance at 232 nm on Perkin Elmer 
Lambda 25 UV/VIS Spectrometer. Regression analysis was 
performed and MCZ concentration in the tablet was determined.  
International Journal of Applied Pharmaceutics 
ISSN- 0975-7058                               Vol 10, Issue 4, 2018 
Bhide et al. 
Int J App Pharm, Vol 10, Issue 4, 2018, 141-146 
 
142 
Compatibility studies between the drug and excipients by IR 
spectroscopy 
The infrared absorption spectrum was obtained by preparing a 
simple physical mixture of the drug and the carrier/excipient in 1:1 
(w/w) ratio. The mixture was then placed on the stage of the 
instrument and scanned by the passage of an IR beam through it. 
The spectra were scanned over a frequency range 4000-600 cm-1 [2]. 
Preparation of solid dispersions  
Solid dispersions were prepared with drug and polymers by fusion 
method. The polymer was used in a ratio of 1:1, 1:3 and 1:5 w/w of 
drug: polymer. Accurately weighed amount of carrier was melted in 
a porcelain dish at 80-85 °C and to this calculated amount of 
meclizine was added with thorough mixing for 1-2 min followed by 
quick cooling. The dried mass was pulverized, passed through 40 
mesh sieve and stored in a desiccator [2]. 
Evaluation of meclizine solid dispersions 
Physical appearance 
All the batches of meclizine Solid dispersions were evaluated for 
color and appearance. 
Solubility studies 
The solubility studies of prepared solid dispersions were performed 
in 0.1 N HCl, distilled water, and phosphate buffer pH 7.4. An excess 
amount of preparation was weighed and transferred into the conical 
flasks which contain 10 ml of media. The content in conical flask was 
sonicated for 2 h at room temperature, thereafter the samples were 
placed on a Remi® make orbital shaker, agitated at room 
temperature for 48 h. Finally, the suspensions were filtered through 
a membrane filter paper, suitably diluted and analyzed spectro-
photometrically at 232 nm [7]. 
DSC analysis 
The thermal behavior of the prepared solid dispersions of meclizine was 
studied using differential scanning calorimetry (DSC). 3-4 mg of samples 
were weighed into aluminum pan and sealed with the lid having a 
pinhole in the center. Sealed pan-lid was then loaded on DSC instrument 
and heated from 0 °C to 300 °C at a heating rate of 10 °C/min. Nitrogen 
was used as the purge gas for the instrument [7]. 
SEM studies 
The solid dispersions were evaluated for their physical structure 
and to study changes in the surface topography of the drug particles 
by scanning electron microscopy (SEM) technique [7].  
Percent practical yield 
Percent practical yield was calculated to know about percent yield or 
efficiency of the any method thus it helps in selection of appropriate 
method of production [9]. Solid dispersions were collected and weighed 
to determine practical yield (PY) from the following equation:  
PY% =  practical mass Sd
theoretical mass drug + carrier x 100 
Preparation of FDT 
The fast dissolving tablets (FDTs) were prepared for selected solid 
dispersion preparations i.e., SD5, as given in table 1. The solid 
dispersion powder equivalent to 25 mg of MCZ, crospovidone and 
other excipients were passed through a mesh no 60. The powdered 
solid dispersion was mixed with crospovidone. Then spray-dried 
lactose was added and mixed in a poly bag for 5-10 min. The blend 
was then lubricated with purified talc and magnesium stearate for 
another 5 min. The blend was then subjected to preformulation 
studies. The resultant mixture was directly compressed into tablets 
using 10 station rotary tableting machine make Shakti® [9]. 
 
Table 1: Composition of meclizine and control fast dissolving tablet 
Formulation code Ingredients (in mg) 
SD 5 Control 
MCZ solid dispersion equivalent to 25 mg MCZ 125 - 
Pure meclizine - 25 
Crosspovidone (5%) 10 5 
Spray dried lactose 60 65 
Magnesium stearate (1%) 2 2 
Purified talc (2%) 3 3 
Total amount (g) 200 100 
 
Preformulation tests for tablet blend 
Bulk density (Db) was expressed in g/ml and is given by 
Db =  M/Vb 
Where, M is the mass of powder and Vb is the bulk volume of the 
powder [11]. 
Tapped density (Dt) was expressed in g/ml and is given by 
Dt =  M/Vt 
Where, M is the mass of powder and Vt is the tapped volume of the 
powder [11]. 
Angle of repose (q)  
q =  tan − 1 h/r 
Where, q is the angle of repose, h is the height in cm and r is the 
radius in cm [11]. 
Carr’s index (or) % compressibility was expressed in percentage 
and is given below  
I = Dt − DbDt × 100 
Where, Dt is the tapped density of the powder and Db is the bulk 
density of the powder [12]. 
Hausner ratio  
Hausner ratio = DtDb 
Where, Dt is the tapped density and Db is the bulk density [13]. 
Evaluation of fast dissolving tablets 
Weight variation, hardness, friability (F). These tests were 
performed on prepared tablets [11, 14]. 
Wetting time  
A piece of tissue paper folded double was placed in a Petri plate 
(internal diameter is 6.5 cm) containing 6 ml of water. The tablet 
was placed on the paper and the time for complete wetting of the 
tablet was measured in seconds. The method was slightly modified 
by maintaining water at 37 °C [15].  
In vitro drug release 
The release of the drug in vitro was determined by estimating the 
dissolution profile [9]. 
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Dissolution test  
USP 2 (Paddle) apparatus at 50 rpm was used with 900 ml 
phosphate buffer (pH 6.8) as a dissolution medium [11] 
Drug content 
Ten tablets were crushed, and 100 mg of the powder was accurately 
weighed and transferred to a 100 ml volumetric flask. About 50 ml 
of phosphate buffer pH 6.8 was added to the volumetric flask and 
allowed to stand for 6-8 h with intermittent shaking. The solution 
was then filtered and volume was made up to 100 ml with buffer, 
and drug content was determined by UV-visible spectrophotometer 
at 232 nm [9].  
Rapid disintegrating property 
To evaluate the tablets for their rapid disintegration properties, 
following tests were carried out [9]. 
Disintegration test  
A Petri dish (10 cm dia.) was filled with 10 ml of water. The tablet 
was carefully placed at the center of Petri dish and the time for the 
tablet to completely disintegrate into fine particles was noted [16]. 
Water absorption ratio 
A piece of tissue paper folded twice was placed in a small Petri dish 
containing 6 ml of water. A tablet was put on the paper and the time 
required for complete wetting was measured. The wetted tablet was 
then weighed. Water absorption ratio, R, was determined using 
following equation, 
R = 10 Wa/Wb 
Where, Wb is the weight of tablet before water absorption and Wa is 
the weight of tablet after water absorption [9]. 
In vitro dispersion time 
Tablet was added to 10 ml of phosphate buffer solution, pH 6.8 at 
37±0.5 °C. The time required for complete dispersion of a tablet was 
measured [9]. 
RESULTS AND DISCUSSION 
Physical appearance and solubility 
An off-white powder granular product in appearance was obtained.  
Percent practical yield 
The percent practical yield obtained for formulation SD1, SD3 and 
SD5 were 90.12, 94.06 and 94.23% respectively. 
Standard calibration curve of meclizine 
Standard plot of drug concentrations from 0 to 20 µg/ml was 
obtained. The straight line equations and regression coefficients 
obtained for 0.1 N HCl, water and buffer pH 6.8 are y = 
0.0433x+0.0265, R² = 0.9939; y = 0.0586x+0.0029, R² = 0.9943 and 
y = 0.0618x-0.0264, R² = 0.9969, respectively. 
Compatibility studies between meclizine and excipients by IR 
spectroscopy 
No interaction was observed when meclizine and mannitol 1:1 w/w 
mixture was tested. 
Solubility studies 
Solubility measurements of meclizine pure drug and its solid 
dispersions are tabulated in table 2. From the solubility studies of 
the prepared solid dispersions in different media, it was found that 
as the increase in pH of the media increased the solubility i.e. 
meclizine showed superior solubility in phosphate buffer pH 6.8 
when compared with others. 
  
Table 2: Solubility measurements of meclizine pure drug and its solid dispersions 
Formulation code Solubility (mg/ml)±SD* 
0.1 N HCl Distilled water Buffer pH 6.8  
Pure drug 0.322±0.21  0.964±0.15 0.978±0.32 
SD1 0.508±0.19 1.121±0.22 1.429±0.33 
SD3 0.611±0.22 1.321±0.23 1.605±0.21 
SD5 0.698±0.12 1.480±0.11 1.691±0.27 
*mean±standard deviation (SD), n=3 
 
DSC and SEM studies 
The DSC thermogram of meclizine showed a sharp endothermic 
peak at 216.32 °C (fig. 1 a) corresponding to its melting point, 
indicating its crystalline nature. The DSC thermogram of solid 
dispersion SD5 showed a sharp endothermic peak at 167.22 ° C, 
corresponding to the melting point of mannitol (fig. 1b). The 
absence of the endothermic peak of meclizine in the thermograms 
suggests that meclizine has probably solubilised in the melted 
mannitol. Due to the absence of the endothermic peak of meclizine 
in the solid dispersions, SD5 studies reveal that drug was no 
longer present in crystalline form and probably molecularly 




Fig. 1: DSC thermogram of meclizine (a) and solid dispersion SD5 (b) 
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The MCZ crystals are usually fine needles with smooth surfaces, partially 
agglomerated in bundles. The SEM result shows that in the case of solid 
dispersion of MCZ particles were in almost amorphous form, which 
indicates a reduction in particle size. The photomicrographs (fig. 2) of 
the solid dispersion show that MCZ might have dispersed in the carrier. 
These observations provide the evidence of solid dispersion formation. 
 
 
Fig. 2: SEM images of solid dispersion SD5 
 
 
Fig. 3: In vitro drug release profile of meclizine pure drug, solid dispersion SD1, SD3 and SD5 (n=3) 
 
Dissolution profile of meclizine pure drug and solid dispersion 
Meclizine pure drug and SD1, SD3 and SD5 formulations showed 
12.8, 31.68, 38.92 and 53.28% cumulative drug release in phosphate 
buffer pH 6.8 after 60 min, respectively as shown in fig. 3. 
Statistical analysis 
The in vitro drug release data of the selected solid dispersions-SD1, 
SD3 and SD5 were treated to first order, Higuchi diffusion plot [17] 
and Peppa’s exponential. The R values for first-order plots were 
significantly higher as compared to zero order plots which indicate 
that all the formulations best fitted in first order kinetics and poorly 
fitted in zero order kinetics. The first-order plot was found to be 
fairly linear indicating that the drug release followed first order 
kinetics, with solid dispersion SD5 showing the highest R2 value of 
0.991. Similarly, the data was treated according to Higuchi’s 
diffusion equation. The best fit with higher correlation was found 
with the Higuchi’s equation for most of the formulations with the 
highest correlation coefficient (R2=0.969) for solid dispersion SD3. 
The result indicated that all formulations exhibited diffusion 
mechanism in drug release. Further, the data was subjected to 
Peppa’s model where R-value revealed that the Peppa’s model best 
fitted in all dissolution profiles. Peppa’s exponential plot gave slope 
values lesser than 0.5 for solid dispersions SD1 (0.254), SD3 (0.230) 
and SD5 (0.288) indicating that the drug release followed Fick’s Law 
of diffusion. Thus the drug release from solid dispersions is diffusion 
controlled and followed first order kinetics. 
Preformulation tests of fast dissolving tablets 
Results of the bulk density, tap density, angle of repose, Carr’s index and 
Hausner ratio are given in table 3. The resultant bulk and tapped density 
indicated good to fair flowability. The angle of repose results indicates a 
good and passable flow of powdered mixture. Carr’s index or % 
compressibility indicates that resultant the powdered mixture posses’ 
good compressibility. Hausner’s ratio was found to be less than 1.25 
which indicates better flow properties during tableting process. 
 
Table 3: Preformulation parameters for solid dispersion SD5 and control tablets 




Angle of repose ( °) Carr’s index (%) Hausner ratio 
SD5 0.331±1.66 0.387±1.54 28.46±1.72 14.47±1.58 1.160±1.61 
CONTROL 0.338±1.32 0.396±1.43 30.10±1.26 14.64±1.66 1.171±1.63 
*mean±SD, n=3 
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Table 4: Quality control tests for solid dispersion SD5 and control tablets 
Formulation Weight variation (mg)* Hardness (Kg/cm2)** Friability (%)+ Wetting Time (sec)++ 
SD5 201.68±1.31  3.0±0.23  0.34±0.001 11+4 
CONTROL 100.18±1.27 3.0±0.18  0.25±0.001 15+4 
*All values represent mean±standard deviation, n=20; **All values represent mean±standard deviation, n=6;+All values represent mean±standard 
deviation, n=3;++All values represent mean±standard deviation, n=3. 
 
Evaluation of meclizine solid dispersion incorporated fast 
dissolving tablets 
The results of weight variation, hardness, friability and wetting time 
are given in table 4. The tablets were found to comply with 
pharmacopoeial requirements. Fast dissolving tablet of solid 
dispersion SD5 showed faster wetting then controlled fast dissolving 
tablet [16, 18, 19]. 
Dissolution studies 
Percent cumulative drug release for control and solid dispersion 
tablets after 60 min in phosphate buffer pH 6.8 was 92.04 and 98.2% 
respectively. The release of meclizine from SD5 FDT was found to be 
faster than pure drug FDT.  
The overall increase in the dissolution performance of the optimized 
formulation was described in terms of dissolution parameters Initial 
dissolution rate (IDR), Dissolution efficiency (DE), Relative 
dissolution rate (RDR) and when compared with control tablets and 
all the above parameters were increased in case of SD5 FDT 
formulation, as seen in table 5 [20]. 
Drug content  
Drug content of the solid dispersions tablet was found to be 98.3 % and 
that of control tablet was found to be 99.01 %. Both tablets showed the 
presence of high drug content. 
Rapidly disintegrating properties 
Disintegration time was found to be 25 sec for FDT of solid 
dispersion SD5 and 19 sec for control FDT. Water absorption ratio 
was found to be 154 for FDT of solid dispersion SD5 and 146 for 
control FDT. Solid dispersion FDT showed faster disintegration and 
higher water absorption ratio then control tablet [19]. 
  
Table 5: Dissolution parameters of MCZ SD5 and control tablets 
Formulation code Q 20 IDR (%/min) DE RDR 
SD5 97.56±1.46 4.878±1.21 62.37±1.66 2.56±1.23 
Control 38.0±1.61 1.26±1.55 44.53±1.12 
IDR: Initial dissolution rate, DE: Disolution efficiency, RDR: Relative dissolution rate; mean±SD, n=3 
 
CONCLUSION 
The dissolution rate of meclizine from solid dispersion was 
significantly higher than that of pure drug. The general trend indicated 
that there was an increase in dissolution rate for solid dispersion in 
the following order of SD 1:5>SD 1:3>SD 1:1. IR studies indicated that 
no chemical interaction between drug and carrier/excipient took place 
during the preparation of the solid dispersion of meclizine. Aqueous 
solubility studies revealed that solid dispersions SD5 posses higher 
solubility in phosphate buffer pH 6.8. The in vitro release of meclizine 
from solid dispersions SD1, SD3, SD5 were found to be faster than the 
pure drug itself. The cumulative percent drug released after 60 min 
was found to be highest in SD5 followed by SD3 and SD1. The 
prepared fast dissolving tablets blend showed good pre-compression 
properties i.e. the angle of repose, bulk density, tapped density, Carr’s 
index and Hausner ratios and the results were within the limits. The 
control, as well as SD5 fast dissolving tablets, showed weight variation, 
hardness, friability, wetting time, disintegration time, water 
absorption ratio results complying with pharmacopoeial limits. The 
release of meclizine from SD5 fast dissolving tablets was found to be 
faster than pure drug FDT. 
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